在临床前阿尔茨海默病中,自由回忆优于故事回忆在与血生物标志物相关的关系中
A J Aschenbrenner1, J J Hassenstab, S E Schindler
1Andrew Aschenbrenner, PhD, 4488 Forest Park Ave, STE 301, St. Louis, MO, 63108, a.aschenbrenner@wustl.edu, 314-273-1041.
The journal of prevention of Alzheimer's disease
|November 19, 2024
概括
免费回忆记忆测试对阿尔茨海默病生物标志物最敏感. 选择正确的记忆评估,如FCSRT + IR,对于在临床试验中检测认知衰退至关重要.
科学领域:
- 神经学 神经学
- 生物标志物 生物标志物
- 认知科学 认知科学
背景情况:
- 情节性记忆衰退是阿尔茨海默病 (AD) 的早期迹象.
- 插曲性记忆测试是AD临床试验中的关键终点.
- 针对AD的血生物标志物越来越多地可用于试验丰富.
研究的目的:
- 为了比较常见的情节性记忆测试与AD血生物标志物的相关性.
- 为了确定最敏感的记忆测试,以检测早期的AD病理.
主要方法:
- 一项对161名认知正常的老年人的纵向队列研究.
- 评估了使用自由回忆,配对关联者和段落回忆的情节性记忆.
- 测量了等离子体生物标志物,包括Aβ42/Aβ40比率,ptau217和神经纤维光链.
主要成果:
- 自由回忆 (FCSRT + IR) 对与异常Aβ42/Aβ40和ptau217.7相关的认知变化表现出更大的敏感性.
- 仅包括自由回忆在内的认知复合体与基线Aβ42/Aβ40.2相比,表现出更大的下降.
- 对于使用ptau217或NfL.L.的复合材料,差异很小.
结论:
- 在临床前的阿尔茨海默病中,对情节性记忆的评估至关重要.
- 自由回忆测试,特别是FCSRT + IR,在检测AD相关的认知变化方面优于配对的关联或段落回忆.
- 选择最佳的记忆测量对于AD临床试验的成功至关重要.
相关概念视频
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165


